Paper35613596
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.
Pfaff-Kilgore JM and 12 others. Cell Rep, 2022. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Papers, record 35613596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35613596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepacivirus | Major topic |
| Hepatitis C | Major topic |
| Alanine | |
| Antibodies, Monoclonal | |
| Humans | |
| Viral Envelope Proteins | |
| Virus Internalization |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U19 AI159822 | NIAID NIH HHS | United States | U19AI159822 | PubMed and NIH | NIH RePORTER |
| R01 AI127469 | NIAID NIH HHS | United States | R01AI127469 | PubMed and NIH | NIH RePORTER |
| R24 AI158193 | NIAID NIH HHS | United States | R24AI158193 | PubMed and NIH | NIH RePORTER |
| R21 AI151353 | NIAID NIH HHS | United States | R21AI151353 | PubMed and NIH | NIH RePORTER |
| U19 AI123861 | NIAID NIH HHS | United States | U19AI123861 | PubMed and NIH | NIH RePORTER |
| R01 AI123365 | NIAID NIH HHS | United States | R01AI123365 | PubMed and NIH | NIH RePORTER |
| HHSN272201400058C | NIAID NIH HHS | United States | PubMed | PubMed |
References111
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11145889 | The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation. | Virology | 2001 | https://conductscience.org/library/papers/11145889 | PubMed |
| 2 | 22278231 | Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function. | J Virol | 2012 | https://conductscience.org/library/papers/22278231 | PubMed |
| 3 | 29769329 | Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29769329 | PubMed |
| 4 | 16103160 | Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. | J Virol | 2005 | https://conductscience.org/library/papers/16103160 | PubMed |
| 5 | 17374757 | Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. | J Gen Virol | 2007 | https://conductscience.org/library/papers/17374757 | PubMed |
| 6 | 28100619 | Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a trans-Complementation System Reveals a Dual Role of a Putative Fusion Peptide of E1 in both HCV Entry and Morphogenesis. | J Virol | 2017 | https://conductscience.org/library/papers/28100619 | PubMed |
| 7 | 22623528 | Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22623528 | PubMed |
| 8 | 24158478 | Atomic-level functional model of dengue virus Envelope protein infectivity. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24158478 | PubMed |
| 9 | 30068644 | Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain. | J Virol | 2018 | https://conductscience.org/library/papers/30068644 | PubMed |
| 10 | 19891955 | Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/19891955 | PubMed |
| 11 | 15159545 | The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15159545 | PubMed |
| 12 | 22492964 | Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22492964 | PubMed |
| 13 | 11559832 | Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. | J Virol | 2001 | https://conductscience.org/library/papers/11559832 | PubMed |
| 14 | 27121372 | Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain. | Sci Rep | 2016 | https://conductscience.org/library/papers/27121372 | PubMed |
| 15 | 30443787 | Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy. | Arch Immunol Ther Exp (Warsz) | 2019 | https://conductscience.org/library/papers/30443787 | PubMed |
| 16 | 36264808 | Structure of the hepatitis C virus E1E2 glycoprotein complex. | Science | 2022 | https://conductscience.org/library/papers/36264808 | PubMed |
| 17 | 25172800 | HCV E2 core structures and mAbs: something is still missing. | Drug Discov Today | 2014 | https://conductscience.org/library/papers/25172800 | PubMed |
| 18 | 27543332 | Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27543332 | PubMed |
| 19 | 29253863 | Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis. | PLoS Pathog | 2017 | https://conductscience.org/library/papers/29253863 | PubMed |
| 20 | 10400776 | Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. | J Virol | 1999 | https://conductscience.org/library/papers/10400776 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42945244 | Hepatitis C viral variants bear signatures of de novo CD8+ T cell and antibody pressure after spontaneous postpartum viral suppression. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42945244 | PubMed |
| 42642377 | Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers. | Nat Commun | 2026 | https://conductscience.org/library/papers/42642377 | PubMed |
| 41939904 | Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939904 | PubMed |
| 41542449 | mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542449 | PubMed |
| 41481431 | Antibody responses to a highly conserved peptide in HCV E2 protein correlate with chronicity or spontaneous clearance of HCV infection. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41481431 | PubMed |
| 41076628 | Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design. | Cell Rep | 2025 | https://conductscience.org/library/papers/41076628 | PubMed |
| 40766312 | Non-cognate ligands of hepatitis C virus envelope broadly neutralizing antibodies induce virus-neutralizing sera in mice. | Front Immunol | 2025 | https://conductscience.org/library/papers/40766312 | PubMed |
| 40153382 | Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40153382 | PubMed |
| 39232163 | The hepatitis C virus envelope protein complex is a dimer of heterodimers. | Nature | 2024 | https://conductscience.org/library/papers/39232163 | PubMed |
| 38833465 | The red alga Porphyridium as a host for molecular farming: Efficient production of immunologically active hepatitis C virus glycoprotein. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38833465 | PubMed |
| 38793684 | Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development. | Viruses | 2024 | https://conductscience.org/library/papers/38793684 | PubMed |
| 38171391 | A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns. | Virus Res | 2024 | https://conductscience.org/library/papers/38171391 | PubMed |
| 38107333 | HCV E1 influences the fitness landscape of E2 and may enhance escape from E2-specific antibodies. | Virus Evol | 2023 | https://conductscience.org/library/papers/38107333 | PubMed |
| 38084956 | Hepatitis C virus modified sE2F442NYT as an antigen in candidate vaccine facilitates human immune cell activation. | J Virol | 2024 | https://conductscience.org/library/papers/38084956 | PubMed |
| 37432947 | Structures of the Hepaci-, Pegi-, and Pestiviruses envelope proteins suggest a novel membrane fusion mechanism. | PLoS Biol | 2023 | https://conductscience.org/library/papers/37432947 | PubMed |
| 37419906 | Signatures of VH1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins. | Nat Commun | 2023 | https://conductscience.org/library/papers/37419906 | PubMed |
| 37407593 | Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies. | Nat Commun | 2023 | https://conductscience.org/library/papers/37407593 | PubMed |
| 37243237 | Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies. | Viruses | 2023 | https://conductscience.org/library/papers/37243237 | PubMed |
| 36920705 | Pseudotyped Virus for Flaviviridae. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/36920705 | PubMed |
| 36264808 | Structure of the hepatitis C virus E1E2 glycoprotein complex. | Science | 2022 | https://conductscience.org/library/papers/36264808 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD81 | 975 | PubTator's text mining | https://conductscience.org/library/genes/975 | NCBI Gene |
| CLDN1 | 9076 | PubTator's text mining | https://conductscience.org/library/genes/9076 | NCBI Gene |
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
| OCLN | 100506658 | PubTator's text mining | https://conductscience.org/library/genes/100506658 | NCBI Gene |
| SCARB1 | 949 | PubTator's text mining | https://conductscience.org/library/genes/949 | NCBI Gene |
| SCFV | 652070 | PubTator's text mining | https://conductscience.org/library/genes/652070 | NCBI Gene |
| TCF20 | 6942 | PubTator's text mining | https://conductscience.org/library/genes/6942 | NCBI Gene |
| VLDLR | 7436 | PubTator's text mining | https://conductscience.org/library/genes/7436 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35613596
GET https://conductscience.org/api/papers/v1/35613596/references?page=2